 |
priliximab |
|---|---|
| Trade Name | |
| Orphan Indication | Myelofibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2017-09-18 00:00:00 |
| Sponsor | Onco Therapies, Inc.;2265 East Foothill Boulevard;Pasadena, California, 91107 |
Related Access Program
| |
priliximab |
|---|---|
| Trade Name | |
| Orphan Indication | Myelofibrosis |
| USA Market Approval | USA |
| USA Designation Date | 2017-09-18 00:00:00 |
| Sponsor | Onco Therapies, Inc.;2265 East Foothill Boulevard;Pasadena, California, 91107 |